Vimarsana
Biggest News Aggregation in the World

Page 11 - Refractive Error News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Refractive Error. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Refractive Error Today - Breaking & Trending Today

Ophthalmic Lasers Market to Reach $1.90 Bn, Globally, by 2030 at 4.7% CAGR: Allied Market Research - Vimarsana News

Ophthalmic Lasers Market to Reach $1.90 Bn, Globally, by 2030 at 4.7% CAGR: Allied Market Research

Surge in the number of eye-related diseases and advancements in laser technology drive the growth of the global ophthalmic lasers market. PORTLAND, Ore., March 22, 2022 /PRNewswire/ --

New Contact Lens Elutes Antihistamine for Ocular Allergy - Vimarsana News

New Contact Lens Elutes Antihistamine for Ocular Allergy

A new contact lens that elutes antihistamine has been approved by the US Food and Drug Administration as a treatment for ocular allergies.

Specialized Spectacles Slow Myopia During Lockdown - Vimarsana News

Specialized Spectacles Slow Myopia During Lockdown

Spectacles designed to slow the progression of myopia appear to work even during a COVID-19 lockdown.

Ophthalmologist Who Developed Medical Botox Dies at 89 - Vimarsana News

Ophthalmologist Who Developed Medical Botox Dies at 89

He found the drug, once a poison and a weapon, to be effective for treatment of obscure eye diseases before it became the blockbuster fix for wrinkles and treating excessive perspiration.

FDA Approves Eye Drops for Presbyopia - Vimarsana News

FDA Approves Eye Drops for Presbyopia

The first topical preparation to treat presbyopia -- farsightedness caused by loss of elasticity of the lens of the eye, typically occurring in middle and old age -- has won approval from the FDA.